MedTrace Logo

Vaginal Diazepam for the Treatment of Female Pelvic Pain

NCT01938092 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-09-03

Study results available
· View outcomes & findings →

Summary

To determine the efficacy of intravaginal diazepam for the treatment of pelvic pain associated with pelvic floor hypertonic disorder.

Conditions

  • Pelvic Floor Disorders
  • Pelvic Pain

Interventions

DRUG

Diazepam

DRUG

Placebo

Sponsors & Collaborators

  • Raymond Foster

    lead OTHER

Principal Investigators

  • Raymond T Foster, MD · University of Missouri-Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2017-03-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01938092 on ClinicalTrials.gov